Cargando…

Implication of Urinary Complement Factor H in the Progression of Immunoglobulin A Nephropathy

BACKGROUND: After activation, the complement system is involved in the pathogenesis of Immunoglobulin A nephropathy (IgAN). Complement factor H (CFH) is a crucial inhibitory factor of the alternative pathway of the complement system. The study investigated the effects of urinary CFH levels on IgAN p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Maojing, Chen, Yuqing, Zhou, Jingjing, Liu, Ying, Wang, Fengmei, Shi, Sufang, Zhao, Yanfeng, Wang, Suxia, Liu, Lijun, Lv, Jicheng, Zhang, Hong, Zhao, Minghui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4452759/ https://www.ncbi.nlm.nih.gov/pubmed/26035554 http://dx.doi.org/10.1371/journal.pone.0126812

Ejemplares similares

Urinary CXCL1: A Novel Predictor of IgA Nephropathy Progression
por: Zhao, Yanfeng, et al.
Publicado: (2015)

Plasma Soluble Urokinase Receptor Level Is Correlated with Podocytes Damage in Patients with IgA Nephropathy
por: Zhao, Yanfeng, et al.
Publicado: (2015)

The Role of Complement in Microangiopathic Lesions of IgA Nephropathy
por: Li, Jingyi, et al.
Publicado: (2022)

Urinary Uromodulin Excretion Predicts Progression of Chronic Kidney Disease Resulting from IgA Nephropathy
por: Zhou, Jingjing, et al.
Publicado: (2013)

Interaction of uromodulin and complement factor H enhances C3b inactivation
por: Liu, Maojing, et al.
Publicado: (2016)

Evaluation of the Oxford classification in immunoglobulin A vasculitis with nephritis: a cohort study and meta-analysis
por: Yu, Bingxin, et al.
Publicado: (2020)

The predictive value and response to immunosuppressive therapy of IgA nephropathy patients with crescents in a large retrospective Chinese cohort
por: Guo, Yingman, et al.
Publicado: (2023)

Severe Adverse Effects Associated With Corticosteroid Treatment in Patients With IgA Nephropathy
por: Cai, Qingqing, et al.
Publicado: (2017)

Increased plasma sVCAM-1 is associated with severity in IgA nephropathy
por: Zhu, Li, et al.
Publicado: (2013)

Plasma uric acid level indicates tubular interstitial leisions at early stage of IgA nephropathy
por: Zhou, Jingjing, et al.
Publicado: (2014)

Effect of SGLT2 inhibitors on the proteinuria reduction in patients with IgA nephropathy
por: Dong, Yaping, et al.
Publicado: (2023)

Clinical and pathological characteristics in elderly patients with IgA nephropathy
por: Zhang, Yongji, et al.
Publicado: (2023)

Synergistic Effect of Mesangial Cell-Induced CXCL1 and TGF-β1 in Promoting Podocyte Loss in IgA Nephropathy
por: Zhu, Li, et al.
Publicado: (2013)

Complement Activation Is Associated With Crescents in IgA Nephropathy
por: Wang, Zi, et al.
Publicado: (2021)

Zonulin, as a marker of intestinal permeability, is elevated in IgA nephropathy and IgA vasculitis with nephritis
por: Li, Qianqian, et al.
Publicado: (2022)

Role of uromodulin and complement activation in the progression of kidney disease
por: Shen, Fei, et al.
Publicado: (2021)

Secondary IgA Nephropathy Shares the Same Immune Features With Primary IgA Nephropathy
por: Wang, Manliu, et al.
Publicado: (2019)

Potential Involvement of Complement Activation in Kidney Vascular Lesions of Arterionephrosclerosis
por: Chen, Xuejing, et al.
Publicado: (2022)

Glomerular Complement Factor H–Related Protein 5 is Associated with Histologic Injury in Immunoglobulin A Nephropathy
por: Guo, Wei-yi, et al.
Publicado: (2020)

Glomerular C4d Deposition and Kidney Disease Progression in IgA Nephropathy: A Systematic Review and Meta-analysis
por: Jiang, Yuanyuan, et al.
Publicado: (2021)

Pathological significance of urinary complement activation in diabetic nephropathy: A full view from the development of the disease
por: Zheng, Jing‐Min, et al.
Publicado: (2018)

Urinary cMet as a prognostic marker in immunoglobulin A nephropathy
por: An, Jung Nam, et al.
Publicado: (2020)

Urinary complement profile in IgA nephropathy and its correlation with the clinical and pathological characteristics
por: Wang, Dongqing, et al.
Publicado: (2023)

Complement activation products in the circulation and urine of primary membranous nephropathy
por: Zhang, Mu-fan, et al.
Publicado: (2019)

Urinary complement proteins and risk of end-stage renal disease: quantitative urinary proteomics in patients with type 2 diabetes and biopsy-proven diabetic nephropathy
por: Zhao, L., et al.
Publicado: (2021)

Osteopontin Gene Polymorphism and Urinary OPN Excretion in Patients with Immunoglobulin A Nephropathy
por: Kaleta, Beata, et al.
Publicado: (2019)

Urinary complement proteins in IgA nephropathy progression from a relative quantitative proteomic analysis
por: Niu, Xia, et al.
Publicado: (2023)

A Comparative Study of the Gut Microbiota Associated With Immunoglobulin a Nephropathy and Membranous Nephropathy
por: Dong, Ruijuan, et al.
Publicado: (2020)

Case Report: A Pathogenic Missense Variant of WT1 Cosegregates With Proteinuria in a Six-Generation Chinese Family With IgA Nephropathy
por: Li, Qianqian, et al.
Publicado: (2022)

Urinary N-Acetyl-Beta-D-Glucosaminidase levels predict immunoglobulin a nephropathy remission status
por: Liu, Xiao, et al.
Publicado: (2023)

Urinary excretion of β(2)-microglobulin as a prognostic marker in immunoglobulin A nephropathy
por: Shin, Jae Ryung, et al.
Publicado: (2014)

Investigation of the Mechanism of Complement System in Diabetic Nephropathy via Bioinformatics Analysis
por: Xu, Bojun, et al.
Publicado: (2021)

Hyperuricemia as a marker for progression of immunoglobulin A nephropathy
por: Kim, Su-Ji, et al.
Publicado: (2012)

Elevated serum immunoglobulin E level as a marker for progression of immunoglobulin A nephropathy
por: Lee, Ji-Hoon, et al.
Publicado: (2016)

Diagnostic roles of urinary kidney microvesicles in diabetic nephropathy
por: Cai, Fang-Hao, et al.
Publicado: (2020)

Complement induces podocyte pyroptosis in membranous nephropathy by mediating mitochondrial dysfunction
por: Wang, Hui, et al.
Publicado: (2022)

A validation study of crescents in predicting ESRD in patients with IgA nephropathy
por: Zhang, Xiaoyan, et al.
Publicado: (2018)

Elevated Urinary IL-6 Predicts the Progression of IgA Nephropathy
por: Zhao, Wenjun, et al.
Publicado: (2022)

Role of complement in IgA nephropathy
por: Daha, Mohamed R., et al.
Publicado: (2015)

Complement Activation in Patients With Diabetic Nephropathy
por: Bus, Pascal, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1jaersvqdde8j80a0r9r1lr5bv